Huons 

₩19,480
0
+₩180+0.93%Friday 06:30

Statistics

Day High
19,590
Day Low
19,270
52W High
41,500
52W Low
18,800
Volume
12,677
Avg. Volume
29,649
Mkt Cap
226.98B
P/E Ratio
-
Dividend Yield
4.11%
Dividend
800

Upcoming

Dividends

4.11%Dividend Yield
Sep 2026
₩200
Jun 2026
₩200
Apr 2026
₩200
Dec 2025
₩570
Sep 2025
₩150
10Y Growth
N/A
5Y Growth
16.49%
3Y Growth
9.14%
1Y Growth
143.75%

Earnings

Nov 12Expected
Q4 2024
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

6.87%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
620.77BRevenue
42.66BNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Huons Co., Ltd. operates as a global healthcare company, providing a broad spectrum of medical solutions designed to enhance human health in South Korea and worldwide. Its extensive product line includes a variety of oral solid medications targeting numerous conditions, such as those affecting the circulatory and metabolic systems, pain and inflammation (antipyretic, analgesic, anti-inflammatory), musculoskeletal and digestive health, allergies (antihistamines), respiratory ailments, infections (antibiotics), and products for general well-being, urogenital issues, and various chemotherapeutic applications. The company also manufactures a comprehensive range of injectable pharmaceuticals. These span categories like anesthetics, pain and fever reducers, anti-inflammatory agents, muscle relaxants, antispasmodics, antihistamines, and treatments for circulatory and respiratory system disorders. Further offerings in this format include adrenocortical hormones, enzymes, minerals, solvents, calcium supplements, hemostatics, antidotes, antibiotics, metabolic aids, hyaluronic acid, wellness formulations, anticoagulants, and specialized products for tissue and cell systems. In addition to its pharmaceutical offerings, Huons provides ophthalmic solutions (eye drops), various biological products, and medical devices. Established in 1965 and headquartered in Seongnam, South Korea, the company was initially known as Kwang Myung Pharm before officially changing its name to Huons Co., Ltd. in June 2003.
Show More
CEO
Su-Young Song
Employees
912
Country
South Korea
ISIN
KR7243070000

Listings

0 Comments

Share your thoughts

FAQ

What is Huons stock price today?▼
The current price of 243070.KQ is ₩19,480 KRW — it has increased by +0.93% in the past 24 hours. Watch Huons stock price performance more closely on the chart.
What is Huons stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Huons stocks are traded under the ticker 243070.KQ.
Is Huons stock price growing?▼
243070.KQ stock has risen by +3.45% compared to the previous week, the month change is a -7.9% fall, over the last year Huons has showed a -34.19% decrease.
What is Huons market cap?▼
Today Huons has the market capitalization of 226.98B
When is the next Huons earnings date?▼
Huons is going to release the next earnings report on November 12, 2026.
What is Huons revenue for the last year?▼
Huons revenue for the last year amounts to 620.77B KRW.
What is Huons net income for the last year?▼
243070.KQ net income for the last year is 42.66B KRW.
Does Huons pay dividends?▼
Yes, 243070.KQ dividends are paid quarterly. The last dividend per share was 200 . As of today, Dividend Yield (FWD)% is 4.11%.
How many employees does Huons have?▼
As of October 4, 2026, the company has 912 employees.
In which sector is Huons located?▼
Huons operates in the Health & Wellness sector.
When did Huons complete a stock split?▼
The last stock split for Huons was on December 29, 2021 with a ratio of 1.1:1.
Where is Huons headquartered?▼
Huons is headquartered in Seongnam-si, South Korea.